ID31876510
Published Date2020-01-01
JournalWounds : a compendium of clinical research and practice, 2020-01-01, Volume 32 Find other publications in this journal
Author Info
  • Loma Linda University, Vancouver, WA.
  • Crozer Keystone Health System, Springfield, PA.
  • RedC Consultancy, Bradford, United Kingdom.
  • Community Memorial Hospital, Ventura, CA.
  • Hill Country Orthopedic Surgery and Sports Medicine, San Antonio, TX.
  • Barry University SPM, Miami Shores, FL.
  • The Wound Treatment Center, LLC, Opelousas General Health System, Opelousas, LA.
  • Los Robles Hospital, Thousand Oaks, CA.
  • KCI, an Acelity Company, San Antonio, TX and Knutsford, UK; University of Kentucky College of Medicine, Lexington, KY.
  • KCI, an Acelity Company, San Antonio, TX and Knutsford, UK; The University of Manchester, Manchester, UK.
  • and 1 more

Abstract

Impaired wound healing is estimated to affect about 2% of the US population, and a major goal of health care providers (HCPs) is to better understand delayed healing so they can effectively choose advanced wound dressings to manage these wounds. However, there are estimated to be more than 3000 dressing options available, making dressing selection an overwhelming burden. An expert panel of 7 HCPs experienced in diverse medical disciplines and 3 scientists convened to discuss the use of 2 families of dressings (silver-oxysalt [AgOx] dressings and oxidized regenerated cellulose/collagen [ORC/C] dressings) and delayed wound healing. Before the meeting, panelists reviewed 16 articles concerning the dressings, and 2 scientists presented on the topics of infection and inflammation in the wound environment, along with providing information about the dressing families, during the meeting. In addition, each HCP presented specific cases in which they had applied AgOx or ORC/C dressings and described how the dressing was used to manage stalled healing. After the meeting, the panelists and another HCP who was unable to attend the panel meeting provided insight and feedback for this publication, which provides an overview of the meeting. A major theme of this panel discussion was the need for a fundamental change in how HCPs approach wound care, especially for nonhealing wounds and underlying issues of infection and inflammation in the wound environment. Ultimately, the panel developed a decision-tree model for risk-stratifying patients based on their potential to have or develop these 2 underlying issues, followed by deciding on treatment options based on the status of infection and inflammation in the wound.